HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.

Abstract
We investigated the molecular nature of the interaction between the functionally selective M1 muscarinic acetylcholine receptor (mAChR) agonist xanomeline and the human M1 mAChR expressed in Chinese hamster ovary (CHO) cells. In contrast to the non-subtype-selective agonist carbachol, xanomeline demonstrated M1 mAChR binding that was resistant to extensive washout, resulting in a significant reduction in apparent N-[3H]methylscopolamine saturation binding affinity in intact cells. Functional assays, using both M1 mAChR-mediated phosphoinositide hydrolysis and activation of neuronal nitric oxide synthase, confirmed that this persistent binding resulted in elevated basal levels of system activity. Furthermore, this phenomenon could be reversed by the addition of the antagonist atropine. However, pharmacological analysis of the inhibition by atropine of xanomeline-mediated functional responses indicated a possible element of noncompetitive behavior that was not evident in several kinetic and equilibrium binding experimental paradigms. Taken together, our findings indicate for the first time a novel mode of interaction between an mAChR agonist and the M1 mAChR, which may involve unusually avid binding of xanomeline to the receptor. This yields a fraction of added agonist that is retained at the level of the receptor compartment to persistently bind to and activate the receptor subsequent to washout. The results of the current study suggest that elucidation of the mechanism or mechanisms of interaction of xanomeline with the M1 mAChR is particularly important in relation to the potential therapeutic use of this agent in the treatment of Alzheimer's disease.
AuthorsA Christopoulos, T L Pierce, J L Sorman, E E El-Fakahany
JournalMolecular pharmacology (Mol Pharmacol) Vol. 53 Issue 6 Pg. 1120-30 (Jun 1998) ISSN: 0026-895X [Print] United States
PMID9614217 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Muscarinic Agonists
  • Phosphatidylinositols
  • Pyridines
  • Receptor, Muscarinic M1
  • Receptors, Muscarinic
  • Thiadiazoles
  • Atropine
  • Carbachol
  • xanomeline
  • Nitric Oxide Synthase
  • N-Methylscopolamine
Topics
  • Animals
  • Atropine (pharmacology)
  • CHO Cells
  • Carbachol (pharmacology)
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Humans
  • Muscarinic Agonists (metabolism)
  • N-Methylscopolamine (metabolism)
  • Nitric Oxide Synthase (metabolism)
  • Phosphatidylinositols (metabolism)
  • Pyridines (metabolism)
  • Receptor, Muscarinic M1
  • Receptors, Muscarinic (metabolism)
  • Thiadiazoles (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: